These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8039925)

  • 1. Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence.
    Hogan LH; Klein BS
    Infect Immun; 1994 Aug; 62(8):3543-6. PubMed ID: 8039925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages.
    Klein BS; Chaturvedi S; Hogan LH; Jones JM; Newman SL
    Infect Immun; 1994 Aug; 62(8):3536-42. PubMed ID: 8039924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Paracoccidioides brasiliensis AMY1 in a Histoplasma capsulatum amy1 mutant, relates an α-(1,4)-amylase to cell wall α-(1,3)-glucan synthesis.
    Camacho E; Sepulveda VE; Goldman WE; San-Blas G; Niño-Vega GA
    PLoS One; 2012; 7(11):e50201. PubMed ID: 23185578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1,3)-glucan.
    Klimpel KR; Goldman WE
    Infect Immun; 1988 Nov; 56(11):2997-3000. PubMed ID: 3169995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism.
    Rooney PJ; Sullivan TD; Klein BS
    Mol Microbiol; 2001 Feb; 39(4):875-89. PubMed ID: 11251809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming DNA integrates at multiple sites in the dimorphic fungal pathogen Blastomyces dermatitidis.
    Hogan LH; Klein BS
    Gene; 1997 Feb; 186(2):219-26. PubMed ID: 9074500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Eng1 β-Glucanase Enhances Histoplasma Virulence by Reducing β-Glucan Exposure.
    Garfoot AL; Shen Q; Wüthrich M; Klein BS; Rappleye CA
    mBio; 2016 Apr; 7(2):e01388-15. PubMed ID: 27094334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion.
    Klein BS
    Curr Opin Microbiol; 2000 Aug; 3(4):339-43. PubMed ID: 10972490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14.
    Newman SL; Chaturvedi S; Klein BS
    J Immunol; 1995 Jan; 154(2):753-61. PubMed ID: 7529285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell wall composition of two strains of Blastomyces dermatitidis exhibiting differences in virulence for mice.
    Cox RA; Best GK
    Infect Immun; 1972 Apr; 5(4):449-53. PubMed ID: 4636784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cell surface molecules of Blastomyces dermatitidis in the pathogenesis and immunobiology of blastomycosis.
    Klein BS
    Semin Respir Infect; 1997 Sep; 12(3):198-205. PubMed ID: 9313291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence.
    Krajaejun T; Wüthrich M; Gauthier GM; Warner TF; Sullivan TD; Klein BS
    Infect Immun; 2010 Jun; 78(6):2522-8. PubMed ID: 20368350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii.
    Steenbergen JN; Nosanchuk JD; Malliaris SD; Casadevall A
    Infect Immun; 2004 Jun; 72(6):3478-88. PubMed ID: 15155655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast.
    Zhang MX; Brandhorst TT; Kozel TR; Klein BS
    Infect Immun; 2001 Dec; 69(12):7559-64. PubMed ID: 11705933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.
    Brandhorst TT; Wüthrich M; Warner T; Klein B
    J Exp Med; 1999 Apr; 189(8):1207-16. PubMed ID: 10209038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cell-surface molecules of Blastomyces dermatitidis in host-pathogen interactions.
    Klein BS; Newman SL
    Trends Microbiol; 1996 Jun; 4(6):246-51. PubMed ID: 8795162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin.
    Brandhorst T; Klein B
    J Biol Chem; 2000 Mar; 275(11):7925-34. PubMed ID: 10713109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evasion of innate immune responses: evidence for mannose binding lectin inhibition of tumor necrosis factor alpha production by macrophages in response to Blastomyces dermatitidis.
    Koneti A; Linke MJ; Brummer E; Stevens DA
    Infect Immun; 2008 Mar; 76(3):994-1002. PubMed ID: 18070904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous mutant of Blastomyces dermatitidis attenuated in virulence for mice.
    Brass C; Volkmann CM; Philpott DE; Klein HP; Halde CJ; Stevens DA
    Sabouraudia; 1982 Jun; 20(2):145-58. PubMed ID: 7112336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yeast-phase virulence requirement for α-glucan synthase differs among Histoplasma capsulatum chemotypes.
    Edwards JA; Alore EA; Rappleye CA
    Eukaryot Cell; 2011 Jan; 10(1):87-97. PubMed ID: 21037179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.